Otylia Kowal-Bielecka
Overview
Explore the profile of Otylia Kowal-Bielecka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
3922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denton C, Kowal-Bielecka O, Proudman S, Olesinska M, Worm M, Papa N, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39909490
Objectives: The primary objective was the safety of subcutaneous immunoglobulin, IgPro20 (Hizentra, CSL Behring) in adults with diffuse cutaneous systemic sclerosis (dcSSc). Secondary objectives included pharmacokinetics and relative bioavailability of...
2.
Raciborska A, Pieklarz B, Gindzienska-Sieskiewicz E, Zonenberg A, Kowal-Bielecka O, Konopinska J, et al.
Front Med (Lausanne)
. 2025 Jan;
11:1513679.
PMID: 39886453
Purpose: Systemic sclerosis (SSc) affects blood vessels, internal organs, and skin. In ophthalmology, SSc impacts the choroid. The choroidal vascularity index (CVI) measures the vascular component of the choroid and...
3.
Del Galdo F, Lescoat A, Conaghan P, Bertoldo E, colic J, Santiago T, et al.
Ann Rheum Dis
. 2025 Jan;
84(1):29-40.
PMID: 39874231
Objectives: To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods: An international task force was...
4.
Dobrota R, Garaiman A, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, et al.
RMD Open
. 2024 Nov;
10(4).
PMID: 39608865
Objective: Systemic sclerosis Impact of Disease (ScleroID) is the first comprehensive patient-reported outcome measure (PROM) specifically developed for systemic sclerosis (SSc). We investigated the performance of ScleroID in patients with...
5.
Pieklarz B, Gindzienska-Sieskiewicz E, Zawadzka I, Bagrowska M, Daniluk J, Palewski M, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 Dec;
262(5):1475-1487.
PMID: 38133798
Purpose: The aim of this study was to investigate choroidal parameters in patients with systemic sclerosis (SSc) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-SD-OCT) and to determine their...
6.
Pieklarz B, Gindzienska-Sieskiewicz E, Zawadzka I, Bagrowska M, Daniluk J, Sidorczuk P, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1273438.
PMID: 37915331
Introduction: Patients with systemic sclerosis (SSc) present an increased risk of developing glaucomatous optic neuropathy (GON). We investigated peripapillary choroidal parameters and peripapillary retinal nerve fiber layer (RNFL) thickness using...
7.
Pieklarz B, Gindzienska-Sieskiewicz E, Zawadzka I, Bagrowska M, Daniluk J, Konopinska J, et al.
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979818
Purtscher-like retinopathy (PLR) is an uncommon occlusive microangiopathy associated with various systemic conditions. We report a case of PLR related to severe progressive systemic sclerosis (SSc), an autoimmune disease characterized...
8.
Saketkoo L, Escorpizo R, Varga J, Keen K, Fligelstone K, Birring S, et al.
Front Pharmacol
. 2022 Oct;
13:979788.
PMID: 36313333
The World Health Organization (WHO) introduced the International Classification of Functioning, Disability, and Health (ICF) as a scientific method of disability data collection comprised of >1,200 categories describing the spectrum...
9.
Piotrowski W, Martusewicz-Boros M, Bialas A, Barczyk A, Batko B, Blasinska K, et al.
Adv Respir Med
. 2022 Oct;
90(5):425-450.
PMID: 36285980
The recommendations were developed as answers to previously formulated questions concerning everyday diagnostic and therapeutic challenges. They were developed based on a review of the current literature using the GRADE...
10.
Hoffmann-Vold A, Brunborg C, Airo P, Ananyeva L, Czirjak L, Guiducci S, et al.
Chest
. 2022 Oct;
163(3):586-598.
PMID: 36244404
Background: Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort. Research Question: Do enrichment strategies for progressive ILD...